DepYmed is currently developing potent inhibitors of the enzyme PTP1B as therapeutics for cancer and rare diseases. In addition, DepYmed has developed a portfolio of novel small molecules with copper chelating properties that can be applied as potential therapeutic agents for multiple diseases including Wilson Disease and cancer.
Company Details
- Employees
- 2
- Founded
- 2014
- Address
- 3 Bioscience Park Dr, Farmingdale,new York 11735,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.depymed.com
- HQ
- Farmingdale, New York
Depymed, Inc. Questions
Depymed, Inc.'s website is http://www.depymed.com
Depymed, Inc.'s LinkedIn profile is https://www.linkedin.com/company/depymed
Depymed, Inc. has
2 employees.
View email and phone details for 2
employees at Depymed, Inc..
Depymed, Inc.'s industry is
Biotechnology Research
Depymed, Inc.'s top competitors are
Cytospar,
Espervita Therapeutics,
Vitranu,
Amino Therapeutics,
Accredo Specialty Pharmacy,
Combangio, Inc.,
Viamet Pharmaceuticals,
Gromit Therapeutics,
Prevail Partners Llc,
Acadia Pharmaceuticals Inc..
Depymed, Inc.'s categories are Biotechnology Research
Depymed, Inc.'s founding year is 2014
